A stealthy approach to antineoplastic therapy
- 3 Downloads
Liposomal delivery mechanisms are increasingly being seen as a useful vehicle to deliver drugs to the body. A new liposomal formulation has been developed to enable specific targeting of chemotherapy to tumours, delegates were told at the 23rd European Society for Medical Oncology Congress [ Athens, Greece; November 1998 ]. Pegylated-liposomal doxorubicin appears to have superior efficacy over existing therapies in Kaposi’s sarcoma, and evidence is starting to show that it is active in other cancers.